癌症筛查你做“对”了吗

2016-01-07 佚名 康健人生

专家表示,癌症检查要根据不同年龄不同情况来选择,一些不规范的体检会贻误治疗,而一些体检项目并不能替代早期癌症筛查。有些肿瘤筛查项目对人体具有潜在的致病风险,这就需要肿瘤专业医生根据受检者的具体情况权衡做出选择。 “我每年做钼靶检查都说乳腺没有问题,怎么会突然患上乳癌?”“单位的体检我拍了胸片,没发现我有肺癌”……近年,在防治癌症方面,“早发现早治疗”的观念深入人心,但很多消费者没有想到,

专家表示,癌症检查要根据不同年龄不同情况来选择,一些不规范的体检会贻误治疗,而一些体检项目并不能替代早期癌症筛查。有些肿瘤筛查项目对人体具有潜在的致病风险,这就需要肿瘤专业医生根据受检者的具体情况权衡做出选择。

“我每年做钼靶检查都说乳腺没有问题,怎么会突然患上乳癌?”“单位的体检我拍了胸片,没发现我有肺癌”……近年,在防治癌症方面,“早发现早治疗”的观念深入人心,但很多消费者没有想到,一些安心的体检项目却成了癌症诊断的最大误区。专家表示,癌症检查要根据不同年龄不同情况来选择,一些不规范的体检会贻误治疗,而一些体检项目并不能替代早期癌症筛查。

误区一:
健康体检就是癌症筛查

普通健康体检范围并不能完全涵盖肿瘤筛查的范围,侧重点也不一样,因此两者不能相提并论。防癌体检,除了早期发现存在于身体内部的肿瘤外,还会分析受检者以后患肿瘤的因素,对受检者进行健康教育和不良生活方式干预。

误区二:
只要是医生,就能做癌症筛查

“术业有专攻”,只有专科肿瘤医生才了解肿瘤的各种性状。现在某些“筛查”有做得太滥之嫌,随便摸两下、随意做点检查,也被视作参加了“筛查”,如此不但查不出肿瘤。更会让受检者放松警惕,反而误事。拿乳腺癌来说,很多地方都在采用的红外线检查,其实它对乳腺癌早诊就没有意义。

误区三:
胸部X光拍片就能查出肺癌

做胸部X光拍片,如果没有发现问题,是不是就不会有肺部肿瘤呢?回答是否定的。胸部X光拍片只能作为对肺部肿瘤的初筛,仅靠X光拍片检查作诊断是不准确的。初筛阳性的患者则必须要进行胸部CT扫描。如果胸部X光拍检查诊断是肺癌,临床就已经到晚期了。

误区四:
项目越多越好

有些肿瘤筛查项目对人体具有潜在的致病风险,这就需要肿瘤专业医生根据受检者的具体情况权衡做出选择。

误区五:
妇科检查正常=无妇科肿瘤

常规妇科检查并不是衡量生殖系统健康与否的唯一标准。常规妇检没事不等于万事大吉。临床上常常会见到检查正常的人,却在不久之后患上妇科肿瘤。许多妇科肿瘤早期是没有症状的,例如卵巢癌,虽然发病率很高,但在I期、II期时患者不会感到有明显症状,因此,单纯依靠普通妇科检查是很难筛查出来肿瘤的。

误区六:
没有症状就不需检查胃肠镜

在我国,胃肠道癌症发病率较高。但绝大部分单位和个人却没有把胃镜、肠镜检查纳入到体检项目中。因为胃镜、肠镜检查的操作会令人感到有些不适,吓退了不少体检者。还有一部分人则是抱着侥幸心理,认为没症状就不会患胃肠道的肿瘤。因此,同意做胃肠镜检查的人几乎有腹泻、腹痛、便血等症状。主动要求进行以上检查项目的人几乎没有。实际上,早期大肠癌往往没有临床症状,有时候出现慢性腹泻、腹痛和消瘦等症状时也常常会被当成普通腹泻来治疗,耽误了早期诊断和治疗。

误区七:
肿瘤是老人的事

很多肿瘤不断“年轻化”,因此筛查绝不单是老人的专利。同时,肿瘤也不是越老越要查。由于老年人前列腺癌的进展非常缓慢,即使得病,大多也不会因此危及生命,因此75岁后没有必要再进行每年一次的前列腺癌筛查。

误区八:
体检前不做好准备

肿瘤专科医生通常需要综合多项检查项目的结果。如果受检者因未做好准备而影响了检查结果,就可能造成漏诊或误诊。宫颈癌筛查时应注意,检查前一两天不宜性生活;做结肠镜前3天,最好吃无渣或少渣半流质饮食。

误区九:
肿瘤标志物正常=无瘤

40岁以上的体检人群,大多会选择检测肿瘤标志物。他们中的绝大部分人会认为,肿瘤标志物可以直接查出肿瘤,如果肿瘤标志物的检查结果在正常范围内,就说明身体中没有得肿瘤。但是,殊不知,临床中的各种肿瘤标志物只能作为肿瘤的辅助诊断指标之一,临床的诊断不能仅仅依靠肿瘤标志物的检查结果来确定。的确,很多肿瘤,特别是当癌症发生时,肿瘤标志物的检验结果可能会明显高于正常,比如:前列腺癌与PSA、肝癌与AFP等,这属于特异性较强的癌指标,它在一定程度上可反映出癌症的存在,但对一些特异性不强的癌症,如:肺癌、胃癌、肠道肿瘤等等,往往在肿瘤标志物检查结果显示正常的时侯,就有可能已经患了癌症。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-16 1dd7d1dam20(暂无匿称)

    有意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-13 Lynee劲飞扬

    死就死了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-11 陈坤

    456

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-11 陈坤

    比较慢推广

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 medsic

    很难普及哦,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 medsic

    很难普及哦,

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 medsic

    很难普及哦,

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 medsic

    很难普及哦,

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=58040, encodeId=57ae58040a6, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da3d1626631, createdName=1dd7d1dam20(暂无匿称), createdTime=Sat Jan 16 22:40:00 CST 2016, time=2016-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56794, encodeId=c5fc56e946b, content=死就死了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55990, encodeId=d724559905b, content=456, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55991, encodeId=9857559917d, content=比较慢推广, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160111/IMG569370686B5ED9208.jpg, createdBy=f9961678406, createdName=陈坤, createdTime=Mon Jan 11 17:26:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536124, encodeId=ab7a153612422, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Sat Jan 09 01:50:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54596, encodeId=9bc554596b6, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:07:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54589, encodeId=01275458972, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54590, encodeId=f0ed5459022, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54591, encodeId=d711545918f, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54592, encodeId=8f0e545921e, content=很难普及哦,, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Fri Jan 08 11:06:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 medsic

    很难普及哦,

    0

相关资讯

盘点:2015年癌症诊断领域亮点,外泌体上榜

一直以来,癌症的诊断研究领域都是学者们关注的重点,近年来随着研究的深入,许多新型的癌症检测技术不断涌现,比如癌症液体活检技术、microRNA检测工具、成像追踪技术等,本文就盘点了2015年癌症诊断领域的研究亮点。 癌症血液检测新技术 虽然实体肿瘤的检测仍然是癌症诊断中的常规程序,但新一代测序等现代技术,已经使科学家们能够更详细地跟踪肿瘤的组织起源。许多肿瘤脱落的细胞中存在称为外泌体

BMC Cancer:神药二甲双胍可以降低甲状腺癌风险吗?

先前有研究表明使用二甲双胍可降低癌症风险,研究者对甲状腺癌进行了一项研究,探究二甲双胍或其他抗糖尿病药物能否降低其风险。研究者使用英国的临床实践研究数据链(CPRD)进行了一项病例对照研究(1995~2014年)。纳入了第一次诊断为甲状腺癌的患者,每例患者根据年龄、性别等匹配六名对照组。校正BMI、吸烟、糖尿病后估计两者间OR和95 % CI。该研究共纳入了1229例甲状腺癌以及7374例对照组。

NEJM:强大的交互工具ProteinPaint可深挖癌症基因组数据

最近,来自圣犹大儿童研究医院的研究人员开发了一种新型的网络应用和数据装置,其就为全球科学家们提供了强大的交互工具帮助他们理解引发儿童癌症的各种突变,相关研究刊登于Nature Genetics杂志上。这种特殊的工具名为ProteinPaint,其可以帮助有效地揭示改变编码蛋白指令且引发儿童癌症的突变,该工具可为当前的工具提供关键的信息,比如其可以揭示突变是新诊断出的还是复发出现的,或者突变是否是在

汤森路透2015全球新药光荣榜

汤森路透数据显示,2015年(截至2015年12月15日,下同),全球共有49个新分子实体(NME)和生物药首次获批并推向市场。另外,全球范围内,已上市药物里有29个重要的产品线延伸首次获得批准,包括新适应症、新剂型或者新复方;21个新分子实体在全球首次获批,但还未上市。 虽然这些数字表明制药和生物技术行业整体上运行良好,但与去年全球59个上市新药相比,数量明显下降。不过,质量远比数量重要,20

华裔医学家发明“咽喉刷”获世卫肯定

中新社多伦多1月2日电 (记者 徐长安)加拿大皇家医学院院士吴宪威联合香港研发团队,在过去16年间研究发明用于检测鼻咽癌的咽喉刷,造福鼻咽癌高发的中国岭南人群。这项技术也得到了世界卫生组织的肯定。 俗称“广东癌”的鼻咽癌常见于中国南方地区,在广东、香港发病率非常高。“这与生活在这一带的中国人的基因有某种联系”,吴宪威接受记者采访时介绍说,根据统计显示,中国地区,特别是华南地区的居民,因为

JAMA:双胞胎研究揭示癌症的家族性风险

以人群为基础的研究家族性癌症风险的估计是癌症风险预测的重要组成部分。